- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zealand Pharma A/S ADR (ZEAL)
Zealand Pharma A/S ADR stock price live, this page displays NASDAQ ZEAL stock exchange data. View the ZEAL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zealand Pharma A/S ADR real time stock price chart below.
What Is the Zealand Pharma A/S ADR Stock Price Today?
The Zealand Pharma A/S ADR stock price today is 17.59.
What Is the Stock Symbol for Zealand Pharma A/S ADR?
The stock ticker symbol for Zealand Pharma A/S ADR is ZEAL.
Is ZEAL the Same as $ZEAL?
$ZEAL is a common way to refer to the Zealand Pharma A/S ADR ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Zealand Pharma A/S ADR Trade On?
Zealand Pharma A/S ADR is listed and trades on the NASDAQ stock exchange.
Is Zealand Pharma A/S ADR a Good Stock to Buy?
Determining whether Zealand Pharma A/S ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Zealand Pharma A/S ADR share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZEAL quote. (ISIN: US98920Y3045)
What Is the Zealand Pharma A/S ADR Stock Price Today?
The Zealand Pharma A/S ADR stock price today is 17.59.
What Is the Stock Symbol for Zealand Pharma A/S ADR?
The stock ticker symbol for Zealand Pharma A/S ADR is ZEAL.
Is ZEAL the Same as $ZEAL?
$ZEAL is a common way to refer to the Zealand Pharma A/S ADR ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Zealand Pharma A/S ADR Trade On?
Zealand Pharma A/S ADR is listed and trades on the NASDAQ stock exchange.
Is Zealand Pharma A/S ADR a Good Stock to Buy?
Determining whether Zealand Pharma A/S ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Zealand Pharma A/S ADR share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZEAL quote. (ISIN: US98920Y3045)
NASDAQ
Currency in USD
17.59
0.00(0.00%)
Closed·
Day's Range
17.47
18.07
52 wk Range
17.47
18.07
Showing Zealand Pharma ADR historical data. For real-time data please try another search
Day's Range
17.4718.07
52 wk Range
17.4718.07
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Zealand Pharma A/S ADR Company Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.
Zealand Pharma A/S ADR Earnings Call Summary for Q1/2025
- Zealand Pharma reported Q1 2025 revenue of 8 million DKK, driven by Segalog license agreement with Novo Nordisk
- Anticipates $1.4 billion upfront payment from Roche in Q2 2025, strengthening cash position to 18 billion DKK
- Projecting net operating expenses of 2-2.5 billion DKK for 2025; confident in achieving profitability without additional capital raising
- Strengthening obesity treatment pipeline with multiple trials; CEO expresses confidence in betralentide's potential
- Analysts maintain strong buy consensus with price targets ranging from $110 to $169 per share
Last Updated: 05/08/2025, 09:21 AM
Read Full TranscriptEarnings
Latest Release
May 08, 2025
EPS / Forecast
-4.75 / --
Revenue / Forecast
8.09M / --
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.